Md. Code Ann., Health Occ. § 8-6D-01
Definitions
Effective Oct 1, 2023Added by Acts 2021, c. 462, § 1, eff. Oct. 1, 2021; Acts 2021, c. 463, § 1, eff. Oct. 1, 2021. Amended by Acts 2023, c. 367, § 1, eff. Oct. 1, 2023; Acts 2023, c. 368, § 1, eff. Oct. 1, 2023.State of Maryland
- (a) In this subtitle the following words have the meanings indicated.
- (b) “ACME” means the Accreditation Commission for Midwifery Education, or a successor organization that is an accrediting agency for midwifery education programs and institutions and is approved by the United States Department of Education.
- (c) “AMCB” means the American Midwifery Certification Board, or a successor organization that is a certifying agency for midwifery education programs and is approved by the National Commission for Certifying Agencies.
- (d) “Applicant” means an individual who has submitted an application to the Board to be licensed as a certified midwife.
- (e) “Board” means the State Board of Nursing.
- (f) “License” means, unless the context requires otherwise, a license issued by the Board to practice certified midwifery.
(g)
- (1) “Licensed certified midwife” means an individual who has been issued a license by the Board under this subtitle to practice certified midwifery.
- (2) “Licensed certified midwife” does not include a licensed direct-entry midwife or a licensed nurse certified as a nurse-midwife under this title.
(h)
- (1) “Practice certified midwifery” means the management and care of essentially normal newborns and of essentially normal women antepartally, intrapartally, and postpartally.
(2) “Practice certified midwifery” includes:
- (i) Family planning and well woman reproductive care;
- (ii) The prescribing of substances commonly used in the practice of midwifery;
- (iii) The prescribing of Schedule II, Schedule III, Schedule IV, and Schedule V controlled dangerous substances commonly used in the practice of midwifery; and
(iv) The dispensing of the substances prescribed in accordance with the provisions of items (ii) and (iii) of this paragraph in the course of treating a patient:
- 1. At a medical facility or clinic that is operated on a nonprofit basis;
- 2. At a health center that operates on a campus of an institution of higher education;
- 3. At a public health facility, a medical facility under contract with a state or local health department, or a facility funded with public funds; or
- 4. With a starter dosage of a drug as authorized under § 8-508 of this title.
Added by Acts 2021, c. 462, § 1, eff. Oct. 1, 2021; Acts 2021, c. 463, § 1, eff. Oct. 1, 2021. Amended by Acts 2023, c. 367, § 1, eff. Oct. 1, 2023; Acts 2023, c. 368, § 1, eff. Oct. 1, 2023.